Home / Pharmacology / Other Pharmacology / Fatty Acid Binding Proteins (FABP) / Fatty Acid Binding Protein Inhibitors / BMS 309403

BMS 309403

Cat. No. 5258 2 Citations Submit a Review Datasheet / COA / SDS
Pricing Availability   Qty
Description: Potent and selective FABP4 inhibitor
Chemical Name: 2-[[2'-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)[1,1'-biphenyl]-3-yl]oxy]-acetic acid
Purity: ≥98% (HPLC)
Datasheet
Citations (2)
Reviews
Biological Activity Technical Data Solubility Calculators Datasheets References

Biological Activity for BMS 309403

BMS 309403 is a potent and selective fatty acid binding protein 4, adipocyte (FABP4) inhibitor (Ki values are <2, 250 and 350 nM for FABP4, FABP3 and FABP5 respectively). Decreases fatty acid uptake in adipocytes in vitro and reduces atherosclerotic lesion area in a mouse model of atherosclerosis. Reduces blood glucose levels and increases insulin sensitivity in a mouse model of obesity. Orally active.

Compound Libraries for BMS 309403

BMS 309403 is also offered as part of the Tocriscreen 2.0 Max. Find out more about compound libraries available from Tocris.

Technical Data for BMS 309403

M. Wt 474.55
Formula C31H26N2O3
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 300657-03-8
PubChem ID 16122583
InChI Key SJRVJRYZAQYCEE-UHFFFAOYSA-N
Smiles CCC1=C(C4=CC=CC=C4)C(C5=CC=CC=C5)=NN1C2=CC=CC=C2C3=CC=CC(OCC(O)=O)=C3

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for BMS 309403

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 47.45 100

Preparing Stock Solutions for BMS 309403

The following data is based on the product molecular weight 474.55. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 2.11 mL 10.54 mL 21.07 mL
5 mM 0.42 mL 2.11 mL 4.21 mL
10 mM 0.21 mL 1.05 mL 2.11 mL
50 mM 0.04 mL 0.21 mL 0.42 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

Product Datasheets for BMS 309403

Certificate of Analysis / Product Datasheet
Select another batch:
Safety Datasheet

References for BMS 309403

References are publications that support the biological activity of the product.

Furuhashi et al (2007) Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447 959 PMID: 17554340

Sulsky et al (2007) Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP). Bioorg.Med.Chem.Lett. 17 3511 PMID: 17502136

Lin et al (2012) BMS309403 stimulates glucose uptake in myotubes through activation of AMP-activated protein kinase. PLoS ONE 7 e44570 PMID: 22952994

If you know of a relevant reference for BMS 309403, please let us know.

View Related Products by Target

View Related Products by Product Action

View all Fatty Acid Binding Protein Inhibitors

Keywords: BMS 309403, BMS 309403 supplier, BMS309403, potent, selective, fatty, acid, binding, protein, adipocyte, aFABP4, inhibitors, inhibits, insulin, sensitivity, atherosclerosis, FABP4, Fatty, Acid, Binding, Proteins, 5258, Tocris Bioscience

2 Citations for BMS 309403

Citations are publications that use Tocris products. Selected citations for BMS 309403 include:

M et al (2021) Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence. Nat Commun 12 5507 PMID: 34535653

Renate et al (2022) Pharmacological Inhibition of Lipid Import and Transport Proteins in Ovarian Cancer. Cancers (Basel) 14 PMID: 36497485

Do you know of a great paper that uses BMS 309403 from Tocris? Please let us know.

Reviews for BMS 309403

There are currently no reviews for this product. Be the first to review BMS 309403 and earn rewards!

Have you used BMS 309403?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review